Boulding Mark Elliott
CIK 1578852
Transactions on file
96
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-10-13 | 2026-10-09 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 192 | $12.3K | -5.7% | open → |
| 2026-10-13 | 2026-10-09 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Exer. | 192 | $7.6K | +53.7% | open → |
| 2026-10-07 | 2026-10-06 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 435 | $27.9K | -5.6% | open → |
| 2026-10-07 | 2026-10-06 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Exer. | 435 | $17.1K | +53.7% | open → |
| 2026-10-07 | 2026-10-05 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 1,638 | $104.9K | -5.4% | open → |
| 2026-10-07 | 2026-10-05 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Exer. | 1,638 | $64.6K | +53.7% | open → |
| 2026-08-19 | 2026-08-17 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 969 | $70.6K | -16.9% | open → |
| 2026-08-19 | 2026-08-17 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 1,844 | $133.5K | -16.3% | open → |
| 2026-08-19 | 2026-08-17 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Exer. | 2,813 | $72.3K | +135.9% | open → |
| 2026-07-08 | 2026-07-06 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 745 | $64.4K | -29.9% | open → |
| 2026-07-08 | 2026-07-06 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 645 | $55.4K | -29.4% | open → |
| 2026-07-08 | 2026-07-06 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 1,036 | $87.4K | -28.2% | open → |
| 2026-07-08 | 2026-07-06 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 387 | $32.2K | -27.1% | open → |
| 2026-07-08 | 2026-07-06 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Exer. | 2,813 | $130.9K | +30.2% | open → |
| 2026-07-08 | 2026-07-06 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 601 | $51.9K | -29.9% | open → |
| 2026-07-08 | 2026-07-06 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 519 | $44.6K | -29.4% | open → |
| 2026-07-08 | 2026-07-06 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 833 | $70.3K | -28.2% | open → |
| 2026-07-08 | 2026-07-06 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 313 | $26.0K | -27.1% | open → |
| 2026-07-08 | 2026-07-06 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Exer. | 2,266 | $89.3K | +53.7% | open → |
| 2026-06-22 | 2026-06-17 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 309 | $24.5K | -23.5% | open → |
| 2026-06-22 | 2026-06-17 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 1,703 | $133.7K | -22.8% | open → |
| 2026-06-22 | 2026-06-17 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Exer. | 2,012 | $93.6K | +30.2% | open → |
| 2026-06-22 | 2026-06-17 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 1,850 | $146.6K | -23.5% | open → |
| 2026-06-22 | 2026-06-17 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 6,600 | $518.1K | -22.8% | open → |
| 2026-06-22 | 2026-06-17 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Exer. | 8,510 | $396.1K | +30.2% | open → |
| 2026-05-19 | 2026-05-15 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 456 | $33.1K | -16.6% | open → |
| 2026-05-19 | 2026-05-15 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 2,356 | $169.8K | -15.9% | open → |
| 2026-05-19 | 2026-05-15 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Exer. | 2,812 | $72.2K | +135.9% | open → |
| 2026-05-12 | 2026-05-08 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 600 | $47.6K | -23.6% | open → |
| 2026-05-12 | 2026-05-08 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 200 | $15.6K | -22.3% | open → |
| 2026-05-12 | 2026-05-08 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Exer. | 800 | $37.2K | +30.2% | open → |
| 2026-05-12 | 2026-05-08 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 1,900 | $150.7K | -23.6% | open → |
| 2026-05-12 | 2026-05-08 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 840 | $65.7K | -22.5% | open → |
| 2026-05-12 | 2026-05-08 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Exer. | 2,740 | $127.5K | +30.2% | open → |
| 2025-01-07 | 2025-01-03 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Grant | 18,000 | $0.00 | — | open → |
| 2025-01-10 | 2025-01-08 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Sale | 1,998 | $88.9K | +36.2% | open → |
| 2025-01-10 | 2025-01-07 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Sale | 1,543 | $70.0K | +33.6% | open → |
| 2025-02-21 | 2025-02-20 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Sale | 1,614 | $80.9K | +20.9% | open → |
| 2025-02-21 | 2025-02-19 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Sale | 1,333 | $66.8K | +20.9% | open → |
| 2025-03-12 | 2025-03-10 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Exer. | 11,249 | $289.0K | +135.9% | open → |
| 2025-03-12 | 2025-03-10 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Exer. | 45,392 | $1.50M | +83.5% | open → |
| 2025-03-12 | 2025-03-11 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Exer. | 1,719 | $56.8K | +83.5% | open → |
| 2025-03-12 | 2025-03-11 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Sale | 5,662 | $300.2K | +14.3% | open → |
| 2025-03-12 | 2025-03-11 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Exer. | 5,662 | $187.0K | +83.5% | open → |
| 2025-03-12 | 2025-03-10 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Sale | 7,762 | $411.8K | +14.2% | open → |
| 2025-03-12 | 2025-03-10 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Sale | 3,487 | $182.2K | +16.0% | open → |
| 2025-03-12 | 2025-03-11 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Sale | 1,719 | $91.1K | +14.3% | open → |
| 2025-03-12 | 2025-03-10 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Sale | 11,398 | $605.5K | +14.1% | open → |
| 2025-03-12 | 2025-03-10 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Exer. | 11,398 | $376.4K | +83.5% | open → |
| 2025-03-12 | 2025-03-10 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Sale | 45,392 | $2.41M | +14.0% | open → |
| 2025-03-14 | 2025-03-12 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Sale | 2,395 | $127.5K | +13.8% | open → |
| 2025-03-14 | 2025-03-12 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Exer. | 2,395 | $79.1K | +83.5% | open → |
| 2025-03-14 | 2025-03-12 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Sale | 13,126 | $699.7K | +13.7% | open → |
| 2025-03-14 | 2025-03-12 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Exer. | 13,126 | $433.4K | +83.5% | open → |
| 2025-05-19 | 2025-05-15 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Sale | 1,929 | $89.1K | +31.2% | open → |
| 2025-05-19 | 2025-05-15 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Exer. | 1,929 | $49.6K | +135.9% | open → |
| 2025-05-19 | 2025-05-16 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Exer. | 883 | $22.7K | +135.9% | open → |
| 2025-05-19 | 2025-05-16 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Sale | 883 | $40.6K | +31.7% | open → |
| 2025-11-19 | 2025-11-17 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 192 | $14.8K | -21.5% | open → |
| 2025-11-19 | 2025-11-17 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 777 | $59.5K | -20.8% | open → |
| 2025-11-19 | 2025-11-17 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 1,843 | $139.4K | -19.9% | open → |
| 2025-11-19 | 2025-11-17 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Exer. | 2,812 | $72.2K | +135.9% | open → |
| 2025-10-09 | 2025-10-07 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 312 | $20.3K | -6.7% | open → |
| 2025-10-09 | 2025-10-07 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 1,306 | $83.3K | -5.0% | open → |
| 2025-10-09 | 2025-10-07 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 1,757 | $110.5K | -3.7% | open → |
| 2025-10-09 | 2025-10-07 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Exer. | 3,375 | $128.6K | +59.0% | open → |
| 2025-10-07 | 2025-10-06 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 2,266 | $147.4K | -6.9% | open → |
| 2025-10-07 | 2025-10-06 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Exer. | 2,266 | $89.3K | +53.7% | open → |
| 2025-10-07 | 2025-10-03 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 877 | $58.5K | -9.1% | open → |
| 2025-10-07 | 2025-10-03 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 838 | $55.1K | -7.8% | open → |
| 2025-10-07 | 2025-10-03 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 550 | $35.4K | -6.0% | open → |
| 2025-10-07 | 2025-10-03 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Exer. | 2,265 | $89.3K | +53.7% | open → |
| 2025-10-07 | 2025-10-03 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 906 | $60.4K | -9.1% | open → |
| 2025-10-07 | 2025-10-03 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 824 | $54.2K | -7.8% | open → |
| 2025-10-07 | 2025-10-03 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 536 | $34.5K | -6.0% | open → |
| 2025-10-07 | 2025-10-03 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Exer. | 2,266 | $89.3K | +53.7% | open → |
| 2025-10-07 | 2025-10-03 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 1,500 | $100.7K | -9.8% | open → |
| 2025-10-07 | 2025-10-03 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 7,400 | $491.7K | -8.8% | open → |
| 2025-10-07 | 2025-10-03 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 6,124 | $400.9K | -7.5% | open → |
| 2025-10-07 | 2025-10-03 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Sale | 3,100 | $199.7K | -6.0% | open → |
| 2025-10-07 | 2025-10-03 | PTCT PTC THERAPEUTICS, INC. | EXEC. VP AND CLO | Exer. | 18,124 | $714.4K | +53.7% | open → |
| 2025-08-19 | 2025-08-15 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Exer. | 2,813 | $72.3K | +135.9% | open → |
| 2025-08-19 | 2025-08-15 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Sale | 2,813 | $136.7K | +24.7% | open → |
| 2025-09-15 | 2025-09-12 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Sale | 905 | $55.4K | -1.0% | open → |
| 2025-09-15 | 2025-09-12 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Exer. | 905 | $34.5K | +59.0% | open → |
| 2025-09-15 | 2025-09-11 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Exer. | 17,838 | $679.6K | +59.0% | open → |
| 2025-09-15 | 2025-09-11 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Sale | 17,838 | $1.09M | -0.7% | open → |
| 2025-09-15 | 2025-09-11 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Exer. | 2,356 | $89.8K | +59.0% | open → |
| 2025-09-15 | 2025-09-11 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Sale | 2,356 | $143.7K | -0.7% | open → |
| 2025-09-15 | 2025-09-11 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Exer. | 2,470 | $94.1K | +59.0% | open → |
| 2025-09-15 | 2025-09-12 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Sale | 1,019 | $62.5K | -1.2% | open → |
| 2025-09-15 | 2025-09-12 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Exer. | 1,019 | $38.8K | +59.0% | open → |
| 2025-09-15 | 2025-09-12 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Sale | 544 | $33.8K | -2.4% | open → |
| 2025-09-15 | 2025-09-12 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Sale | 22,117 | $1.36M | -1.2% | open → |
| 2025-09-15 | 2025-09-12 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Exer. | 22,661 | $863.4K | +59.0% | open → |
| 2025-09-15 | 2025-09-11 | PTCT PTC THERAPEUTICS, INC. | Officer EXEC. VP AND CLO | Sale | 2,470 | $150.7K | -0.7% | open → |
